B. Lomaestro
American Journal of Health-System Pharmacy · 2008–2020
A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from B. Lomaestro's perspective
Ordered by how strongly the researchers B. Lomaestro trusts endorse each paper. Same corpus, a different order for every researcher.
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections (Clinical Pharmacokinetics)
- Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of… (American Journal of Health-System Pharmacy)
- Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. (Clinical Infectious Diseases)
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug' (Nature Reviews Microbiology)
- High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. (Archives of Internal Medicine)
- Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (Journal of Clinical Microbiology)
- Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. (Clinical Infectious Diseases)
- Autoinduction and signal transduction in the regulation of staphylococcal virulence (Molecular Microbiology)
- Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. (New England Journal of Medicine)
- Guidelines for the Management of Intravascular Catheter-Related Infections (Infection Control & Hospital Epidemiology)
Their papers
- Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Socie (2020) — 1,192 citations
- Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. (2019) — 1,788 citations
- Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. (2009) — 816 citations
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin (2008) — 607 citations